IGC Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
CEORam Mukunda
CEORam Mukunda
Employees70
Employees70
HeadquartersPotomac, Maryland
HeadquartersPotomac, Maryland
Founded2005
Founded2005
Employees70
Employees70
IGC Key Statistics
Market cap36.70M
Market cap36.70M
Price-Earnings ratio-5.01
Price-Earnings ratio-5.01
Dividend yield—
Dividend yield—
Average volume983.20K
Average volume983.20K
High today$0.4501
High today$0.4501
Low today$0.38
Low today$0.38
Open price$0.3956
Open price$0.3956
Volume2.97M
Volume2.97M
52 Week high$0.4985
52 Week high$0.4985
52 Week low$0.2525
52 Week low$0.2525
IGC News
TipRanks 18h
IGC Pharma expands AI-powered in-Silico drug discovery platformIGC Pharma (IGC) announced an expansion of its AI-powered in-Silico drug discovery platform. The company is now integrating more methodologies, including retros...
People also own
Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.